MLL REARRANGEMENT
Clinical trials for MLL REARRANGEMENT explained in plain language.
Never miss a new study
Get alerted when new MLL REARRANGEMENT trials appear
Sign up with your email to follow new studies for MLL REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail takes aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial is testing a new drug called ziftomenib combined with standard chemotherapy or another targeted drug for people with relapsed or treatment-resistant acute myeloid leukemia (AML) that has specific genetic changes. The main goal is to see if these combination…
Matched conditions: MLL REARRANGEMENT
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stem cell test may forecast leukemia return
Knowledge-focused Recruiting nowThis observational study looks at whether leukemia stem cells can predict if acute myeloid leukemia (AML) with MLL rearrangement will come back. Researchers will measure these stem cells in bone marrow samples taken during regular check-ups. The goal is to improve relapse predict…
Matched conditions: MLL REARRANGEMENT
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC